Ixontics Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 52.02%
- Profit Growth -0.99%
- Ebitda 33.38%
- Net Worth 22.77%
- Total Assets -9.78%
About Ixontics Biosciences
Ixontics Biosciences Private Limited (IBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 May 2016 (Eight years and nine months 8 days old ). Its registered office is in Bhubaneswar, Orissa.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Om Das and Vivek Chowdhry serve as directors at the Company.
Company Details
-
LocationBhubaneswar, Orissa
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999OR2016PTC025175
-
Company No.
025175
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 May 2016
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Ixontics Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Om Das
|
Additional Director | 20-Dec-2017 | Current |
|
Vivek Chowdhry
|
Director | 02-May-2016 | Current |
Financial Performance of Ixontics Biosciences.
Ixontics Biosciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 52.02% increase. The company also saw a slight decrease in profitability, with a 0.99% decrease in profit. The company's net worth Soared by an impressive increase of 22.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ixontics Biosciences?
Unlock access to Ixontics Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Frauens Secret LlpVivek Chowdhry is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ixontics Biosciences?
Unlock and access historical data on people associated with Ixontics Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ixontics Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ixontics Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
